Literature DB >> 25524466

Pretreatment maximum standardized uptake value of (18)F-fluorodeoxyglucose positron emission tomography as a predictor of distant metastasis in adenoid cystic carcinoma of the head and neck.

Donghyun Kim1, Wontaek Kim1, Joohye Lee1, Yongkan Ki1, Byungjoo Lee2, Kyusup Cho2, Seongjang Kim3, Jiho Nam4, Jinchoon Lee5, Dongwon Kim1.   

Abstract

BACKGROUND: The purpose of this study was to determine whether the maximum standardized uptake value (SUVmax) of the primary tumor on pretreatment (18)F-fluorodeoxyglucose positron emission tomography ((18)F-FDG PET) has prognostic significance in patients with adenoid cystic carcinoma (ACC) of the head and neck.
METHODS: A retrospective review was carried out on 34 patients with ACC of the head and neck who underwent pretreatment (18)F-FDG PET imaging from June 2005 through July 2009. All patients underwent surgery with curative intent, and 26 of them received adjuvant radiotherapy (RT).
RESULTS: When subjects were stratified into 2 groups according to a cutoff value for SUVmax of 4.15, the risk of distant metastasis was significantly high in patients with high SUVmax (p = .014). Multivariate analysis showed that high SUVmax and histologic grade 3 were independent poor prognostic factors for distant metastasis-free and disease-free survival.
CONCLUSION: Pretreatment SUVmax of the primary tumor is an independent prognostic factor in patients with ACC of the head and neck.
© 2015 Wiley Periodicals, Inc.

Entities:  

Keywords:  18F-fluorodeoxyglucose positron emission tomography (FDG PET); adenoid cystic carcinoma; head and neck cancer; prognosis; standardized uptake value

Mesh:

Substances:

Year:  2015        PMID: 25524466     DOI: 10.1002/hed.23953

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  6 in total

Review 1.  Adenoid cystic carcinoma: focus on heavy ion therapy and molecular imaging.

Authors:  Angelo Castello; Laura Olivari; Egesta Lopci
Journal:  Am J Nucl Med Mol Imaging       Date:  2018-02-05

Review 2.  Beyond Surgical Treatment in Adenoid Cystic Carcinoma of the Head and Neck: A Literature Review.

Authors:  Sarah Atallah; Morgane Marc; Antoine Schernberg; Florence Huguet; Isabelle Wagner; Antti Mäkitie; Bertrand Baujat
Journal:  Cancer Manag Res       Date:  2022-06-04       Impact factor: 3.602

3.  Risk factors for survival and distant metastasis in 125 patients with head and neck adenoid cystic carcinoma undergoing primary surgery.

Authors:  In Seong Jeong; Jong-Lyel Roh; Kyung-Ja Cho; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2020-03-06       Impact factor: 4.553

4.  Pre-treatment metabolic tumor volume predicts tumor metastasis and progression in high-grade salivary gland carcinoma.

Authors:  Turki M Almuhaimid; Won Sub Lim; Jong-Lyel Roh; Jungsu S Oh; Jae Seung Kim; Soo-Jong Kim; Seung-Ho Choi; Soon Yuhl Nam; Sang Yoon Kim
Journal:  J Cancer Res Clin Oncol       Date:  2018-10-06       Impact factor: 4.553

5.  Potential role of functional imaging in predicting outcome for patients treated with carbon ion therapy: a review.

Authors:  Giulia Riva; Sara Imparato; Giovanni Savietto; Mattia Pecorilla; Alberto Iannalfi; Amelia Barcellini; Sara Ronchi; Maria Rosaria Fiore; Chiara Paganelli; Giulia Buizza; Mario Ciocca; Guido Baroni; Lorenzo Preda; Ester Orlandi
Journal:  Br J Radiol       Date:  2021-09-14       Impact factor: 3.039

6.  Diagnostic accuracy of 18F-FDG PET/CT and MR imaging in patients with adenoid cystic carcinoma.

Authors:  Verena Ruhlmann; Thorsten D Poeppel; Johannes Veit; James Nagarajah; Lale Umutlu; Thomas K Hoffmann; Andreas Bockisch; Ken Herrmann; Wolfgang Sauerwein
Journal:  BMC Cancer       Date:  2017-12-22       Impact factor: 4.430

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.